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Background. Renal colic is a medical emergency due to the rapid onset and devastating nature of its pain. Opioids and nonsteroidal
anti-inflammatory drugs (NSAIDs) are both used as first-line choices in its management. Aim. This study aimed to compare the
efficacy and safety of opioids and NSAIDs in the management of acute renal colic.Methods. One hundred and fifty-eight patients
were divided into two groups (𝑛 = 79) and received either 10mg morphine or 100mg indomethacin suppositories. The severity
of pain was measured using verbal numeric rating scale at baseline and 20, 40, 60, and 90 minutes after the administration of
analgesics. Drug side effects as well as patients’ vital signs were also recorded. Results. The mean decrease in the pain score during
the first 20 minutes was significantly higher among those who received morphine suppository. However, no significant difference
was observed between the two groups regarding the mean decrease in pain score during the first 40, 60, and 90 minutes after
the admission. Prevalence of drug side effects or changes in the vital signs was not significantly different between the two groups.
Conclusions. Morphine suppositories seem to be more efficient in achieving rapid pain relief comparing to indomethacin.
1. Introduction
Renal colic, as the most common presentation of ureteral
calculi, is characterized by a sudden onset and severe sense of
pain in the flanks which may radiate to the hypochondrium
[1].This pain is caused by the obstruction and the subsequent
increased tension in the urinary tract during the calculi
passage and is commonly compared with the delivery pain.
Increased pressure of the renal pelvis provokes the secretion
of prostaglandins followed by vasodilatation which results
in further increase in the intrarenal pressure as a result of
diuresis and smooth muscle spasm [2, 3]. Renal colic is
generally considered as a serious health problem due to the
devastating nature of the pain and its high prevalence in
general population which results in a considerable number
of lost work days. The annual incidence of renal colic is
reported to be around 16 per 10,000 populationwith a lifetime
incidence of 1–20% [4–6]. Interestingly, an increase in the
incidence of ureteric calculi and renal colic has been observed
during the past decades, most probably due to changes in the
life style of the general population [7].
The current standard management of pain during acute
renal colic episodes includes administration of opioids as
well as nonsteroidal anti-inflammatory drugs (NSAIDs) both
alone and in combinationwith each other.While opioids take
advantages of being inexpensive, potent, and titratable, their
usage is limited due to the fear of respiratory depression,
drug dependency, and potential drug abuse by mimicking
renal colic symptoms in order to receive opioids [8]. Mor-
phine suppositories benefit from a sustained and prolonged
analgesic effect which requires fewer administrations [9] and
could potentially be less favorable for drug abusers who
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mimic renal colic. In addition, administration of morphine
via rectal rout bypasses the need for intravenous catheter
placement and can be given to patients in their first encounter
in the triage room. Moreover, opioids have no effect on
the prostaglandin secretion, as the main cause of pain in
renal colic [10]. NSAIDs, on the other hand, directly inhibit
the prostaglandin effect and, as a result, are probably more
effective than opioids [8, 10]. However, NSAIDs may cause
serious side effects, most notably renal impairment and renal
failure as well as gastrointestinal bleeding [10]. Moreover, in
contrast with opioids, NSAIDs are not titratable and their
analgesic benefits take longer to effect [8].
Currently, the choice between opioids and NSAIDs at the
clinical setting is highly dependent on clinician’s personal
preference and experience as well as institutional protocols
while there is limited data in order to compare the outcome
of these drugs in the management of acute renal colic
[11]. Considering the exceedingly busy setting of emergency
department and the time needed to achieve intravenous
access, the current study was designed to compare the
efficacy and adverse effects of the suppository administrated
morphine and indomethacin used in the management of
renal colic.
2. Methods
The current randomized double-blind clinical trial (IRCT
registration ID: 2014050514297N2) was performed between
March 2011 and March 2013 in the emergency department of
Imam Hospital and Shariati hospital, two tertiary care uni-
versity affiliated teaching hospitals. The Institutional Review
Board has reviewed and approved the process of this study.
Based on the previous studies, a minimum sample size of
79 for each groupwas desired [12].This was based on an alpha
of 0.05, power of 0.90; andmean (𝑀) and standard deviations
(SD) of 24.7 and 9.1 for indomethacin and 27.4 and 9.1 for
morphine, using the following formula:
𝑁 =
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)
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)
(𝑀
1
−𝑀
2
)
2
. (1)
One hundred and fifty-eight patients with a confirmed
diagnosis of renal colic who aged between 18 and 75 years
were enrolled in this study and were randomly allocated into
two groups using permuted-block randomization method
(𝑛 = 79). Based on the patients’ clinical presentation,
the diagnosis of renal colic was primarily made by triage
nurse and was then confirmed by the emergency medicine
resident and the attending physician. The process of the
study was explained to all participants and they were asked
to fill an informed consent before being entered into the
study. Patients were ensured that their personal and clinical
data would not be revealed under any circumstances and
their names were replaced with codes before data entry to
ensure data confidentiality. The exclusion criteria were as
follows: unwillingness to participate in the study or to receive
suppository analgesics, pregnancy, breastfeeding, a history of
current or past drug abuse, analgesic intake during up to 4
hours prior to admission, long-term use of NSAIDs, a drug
history of hypnotic drugs or phenothiazines, a history of
drug hypersensitivity reaction due to morphine or NSAIDs,
diarrhea, peritonitis, and a history of chronic diseases includ-
ing liver disorders, renal disorders, respiratory problems,
gastrointestinal problems, and endocrine disorders.
Patients either received 10mg morphine suppository
(group A) or 100mg indomethacin suppository (group B) for
the management of renal colic, respectively. In order to blind
the observers as well as patients,morphine and indomethacin
suppositories were placed into glass containers labeled as A
and B and were administrated for patients by the resident
of emergency medicine. Only pharmacy section manager of
hospital was aware of the type of suppositories placed into
A and B containers. The primary outcome of the study was
change in the pain score. The secondary outcome of the
study was the safety and tolerability of drugs as measured
by hemodynamic changes and adverse effects. Assessment
of pain was performed using 11-point numeric rating scale
(from 0 for no pain to 10 for most severe pain possible) at
the time of admission and 20, 40, 60, and 90 minutes later.
Intravenous morphine with a dosage of 5mg was suggested
and administrated for each patient every 20 minutes if the
pain remained the same or the patient reported only a minor
pain relief. Drug adverse effects including nausea, vomiting,
dizziness, and drowsiness as well as patients’ vital signs were
also assessed every 20 minutes. Demographic data including
sex and age, pain score reported by patient at various points,
the amount of analgesics needed for pain relief, and the
duration of hospital stay was recorded for each patient.
Data analysis was performed using SPSS software package
for windows version 21 (IBM, USA). Quantitative variables
are expressed as mean ± standard deviation. Repeated
measure analysis and chi-squared test were used in order
to compare quantitative and qualitative variables between
groups, respectively. Effect size (ES) was estimatedwith a 95%
confidence interval (95% CI). 𝑃 values lower than 0.05 were
considered as statistically significant.
3. Results
A total number of 158 cases including 102 (64.6%) male and
56 (35.4%) female cases were enrolled in the current study
(Figure 1). The mean age of the study population was 37.4 ±
11.1 years which was not statistically different between groups
A and B (37.2 ± 10.6 years versus 37.3 ± 11.5 years, 𝑃 = 0.9,
and ES = −0.01 [95% CI = −0.32 to 0.32]). The mean weight
of the study population was 73.8 ± 10.4 kilograms which was
not statistically different between groups A and B (74.1 ± 8.9
kilograms versus 73.4 ± 11.8 kilograms, 𝑃 = 0.9, and ES =
0.07 [95% CI = −0.25 to 0.38]). Male to female ratio was also
similar between groups A and B (1.75 versus 1.88, 𝑃 = 0.6, and
ES=0.74 [95%CI= 0.37 to 1.10]). Table 1 summarizes patients’
demographic data.
Themean pain score at the start of measurements was not
significantly different between the two groups (8.38 ± 1.08
for group A versus 8.26 ± 1.09 for group B, 𝑃 = 0.5, and
ES = 0.1 [95% CI = −0.22 to 0.41]). The mean decrease in
the pain score during the first 20 minutes after the admission
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Table 1: Demographic data of the study population.
Group A Group B Total 𝑃 value EF (95% CI)
Age (year) 37.2 ± 10.6 37.3 ± 11.5 37.4 ± 11.1 0.9 −0.01 (−0.32 to 0.30)
Weight (Kg) 74.1 ± 8.9 73.4 ± 11.8 73.8 ± 10.4 0.9 0.07 (−0.25 to 0.38)
Male/female 1.75 1.88 1.82 0.6 0.74 (0.37 to 1.10)
Group A: patients received morphine suppository.
Group B: patients received indomethacin suppository.
95% CI: 95% confidence interval.
EF: effect size.
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Figure 1: CONSORT diagram showing the flow of participants.
was significantly higher among group A cases who received
morphine suppository comparing to group B who received
indomethacin suppository (5.46 ± 1.34 versus 4.36 ± 1.62,𝑃 <
0.001, and ES = 0.74 [95% CI = 0.44 to 1.06]). However, no
significant difference was observed between the two groups
regarding the mean decrease in pain score during the first
40, 60, and 90 minutes after the admission (Table 2). Figure 2
shows the timeline for pain scores in two study groups. The
mean change in the systolic and diastolic blood pressure
was not also significantly different between the two groups
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Table 2: The mean decrease in the pain score during the first 20, 40, 60, and 90 minutes after the admission in groups A and B.
Duration Group Decrease in the pain score
Mean ± SD 𝑃 value EF (95% CI)
0–20 minutes Group A 5.46 ± 1.34 <0.001∗ 0.73 (0.40 to 1.05)
Group B 4.37 ± 1.63
0–40 minutes Group A 6.26 ± 1.62 0.3 0.16 (−0.18 to 0.45)
Group B 6.04 ± 1.59
0–60 minutes Group A 6.27 ± 1.79 0.5 0.16 (−0.22 to 0.40)
Group B 6.11 ± 1.66
0–90 minutes Group A 6.28 ± 1.75 0.4 0.13 (−0.18 to 0.44)
Group B 6.07 ± 1.67
Group A: patients received morphine suppository.
Group B: patients received indomethacin suppository.
95% CI: 95% confidence interval.
EF: effect size.
SD: standard deviation.
∗Statistically significant.
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Figure 2: Timeline graph of pain scores in the two study groups.
during the first 20, 40, 60, and 90minutes after the admission
(Table 3).
Nausea was reported by 52.7% of patients in group A and
by 47.3% of patients in group B which was not significantly
different (𝑃 = 0.5, ES = 0.11 [95% CI = −0.22 to 0.46]).
Vomiting was reported by 49% of patients in group A and
by 51% of patients in group B which was also not significantly
different (𝑃 = 0.7, ES = −0.04 [95% CI = −0.38 to 0.29]). The
prevalence of dizziness was 43.3% in group A and 56.7% in
group B which was not significantly different (𝑃 = 0.4, ES =
−0.29 [95% CI = −0.64 to 0.04]). Dryness of the mouth was
reported by 48% of patients in groupA and by 52% of patients
in group B which was also not significantly different (𝑃 = 0.4,
ES = −0.08 [95% CI = −0.43 to 0.25]). Allergic drug reactions
were observed in 49.7% of patients in groupA and in 50.3% of
patients in group B which was also not significantly different
(𝑃 = 0.5, EF = −0.01 [−0.35 to 0.33]). Table 4 compares the
adverse effects between the two study groups.
4. Discussion
According to the results of the current study, the mean
pain score was not significantly different between renal colic
patients who received either morphine or indomethacin
suppository. However, those who received morphine experi-
enced a greater relief in pain during the first 20 minutes after
the admission. No differencewas observed between these two
groups regarding the drug side effects including changes in
the systolic and diastolic blood pressures.
In one study, Cordell et al. investigated the differences
regarding the efficacy in pain relief and probable side effects
of intravenous morphine and indomethacin suppositories in
patientswith renal colic [10].Their findings showed that those
who received intravenous morphine achieved a better pain
relief after the first tenminutes but not after 20 and 30minutes
comparing to those who received indomethacin suppository.
This is in accordance with the results of this study in
which morphine suppository was superior comparing to
indomethacin suppository in order to achieve pain relief only
during the first 20 minutes after the admission. Moreover,
similar to the current study, they found no significant differ-
ences regarding the side effects of the two drugs.
Since the analgesic effects of morphine and NSAIDs in
renal colic are achieved via different pathways, one may
conclude that the combination of these drugs would result
in a better pain management or a decrease in the amount of
needed morphine as a drug with a high potential for abuse.
In a study by Engeler et al. two orally administrated NSAIDs,
rofecoxib and diclofenac, were used in combination with
morphine in the management of acute pain of renal colic
[13]. The mean morphine consumption was not significantly
different among patients who received rofecoxib, diclofenac,
or placebo in addition to morphine. Moreover, the pain score
reported by patients was similar among these three groups.
On the contrary, in a study by Safdar et al., renal colic patients
who received a combination of intravenous morphine and
ketorolac, NSAIDs, achieved a better pain relief with a lesser
amount of medication comparing to those who received
either of these two drugs alone [14]. In another study by
Phillips et al. the efficacy of celecoxib, also an NSAID, in the
management of renal colic was evaluated [15]. The authors
reported that celecoxib was not efficient in the facilitation
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Table 3: The mean change in the systolic and diastolic blood pressure among the two groups during the first 20, 40, 60, and 90 minutes after
the admission.
Duration Group Change in the systolic blood pressure Change in the diastolic blood pressure
Mean ± SD 𝑃 value EF (95% CI) Mean ± SD 𝑃 value EF (95% CI)
0–20 minutes Group A 3.18 ± 3.62 0.1 0.16 (−0.9 to 0.53) 0.65 ± 2.34 0.3 0.15 (−0.16 to 0.46)
Group B 2.16 ± 5.37 0.13 ± 4.29
0–40 minutes Group A 1.43 ± 3.33 0.2 −0.2 (−0.51 to 0.12) 0.71 ± 2.39 0.7 0.05 (−0.26 to 0.36)
Group B 2.39 ± 5.98 0.52 ± 4.47
0–60 minutes Group A 1.79 ± 3.98 0.09 −0.28 (−0.59 to 0.04) 0.97 ± 2.81 0.4 0.12 (0.19 to 0.43)
Group B 3.19 ± 5.94 0.52 ± 4.38
0–90 minutes Group A 1.64 ± 3.5 0.09 −0.29 (0.60 to 0.03) 0.92 ± 3.02 0.7 −0.05 (−0.36 to 0.26)
Group B 3.03 ± 5.83 1.06 ± 2.39
Group A: patients received morphine suppository.
Group B: patients received indomethacin suppository.
95% CI: 95% confidence interval.
EF: effect size.
SD: standard deviation.
Table 4: Comparison of adverse effects between the two study groups.
Morphine group Indomethacin group 𝑃 value EF (95% CI)
Nausea 52.7% 47.3% 0.5 0.11 (−0.22 to 0.46)
Vomiting 49% 51% 0.7 −0.04 (−0.38 to 0.29)
Dizziness 43.3% 56.7% 0.4 −0.29 (−0.64 to 0.04)
Mouth dryness 48% 52% 0.4 −0.08 (−0.43 to 0.25)
Allergic reaction 49.7% 50.3% 0.5 −0.01 (−0.35 to 0.33)
95% CI: 95% confidence interval.
EF: effect size.
of the stone passage or decrease in the amount of narcotic
administration was evaluated.
Several studies have focused on finding an alternative
analgesic for opioids in the management of acute pain of
renal colic. Aside from NSAIDs, the efficacy and probable
side effects of paracetamol have also been the subject of
some investigations. In one study, Bektas et al. compared
the intravenous administration of morphine and paraceta-
mol among 146 renal colic patients who visited emergency
department [8]. Their findings showed that intravenously
administratedmorphine and paracetamol were both effective
in achieving pain relief comparing to the placebo with no
significant difference between the two and both drugs were
well tolerated. In another study by Grissa et al. renal colic
patients received either intravenous single-dose paracetamol
or intramuscular single-dose piroxicam, an NSAID, after
being admitted for renal colic at the emergency department
[16]. The authors reported a higher rate of pain relief for
paracetamol comparing to piroxicam 90 minutes after the
administration of these analgesics with minimal side effects
for both drugs (80% versus 48%, resp.). Moreover, the supe-
riority in the efficacy of paracetamol comparing to piroxicam
began to be apparent 45 minutes after the administration of
these drugs.
The current study faces several limitations. First, some of
the most serious side effects of analgesics used in this study
could not be assessed due to the short period of follow-up.
Drug abuse and dependence among those receiving opioids
such as morphine and gastrointestinal bleeding among those
receiving NSAIDs such as indomethacin are more likely to
occur after patient’s discharge from the emergency ward.
However, it should be noted that the potential for abuse
is particular for those who already have a history of drug
abuse and should not be generalized to all patients after
one admission. Second, it has been previously suggested that
nausea and vomiting, which were expected side effects in this
study,may affect patient’s perception of pain by increasing the
level of discomfort [14]. Finally, due to difficulties in obtaining
the desired number of patients, we did not include a group
receiving both morphine and indomethacin which would
help to find out if the combination of these drugs could result
in a better pain management and decrease in the amount of
opioids administrated.
In conclusion, while the effect of analgesics on patients’
vital signs and side effects of both morphine and indometh-
acin do not differ significantly, morphine suppositories seem
to be more efficient in achieving rapid pain relief compar-
ing to their indomethacin counterparts. Hence, morphine
remains as a yet irreplaceable analgesic in the acute manage-
ment of pain among renal colic patients.
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